Theriva Biologics inc (TOVX) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access TOVX Annual Balance Sheets →
By examining balance sheet figures across successive periods, users can identify shifts in Theriva Biologics inc's financial structure and capital allocation.
Quarterly Report, GAAP in USD millions
ITEM
(Jun 30 2026)
(Mar 31 2026) (Dec 31 2025) (Sep 30 2025) (Jun 30 2025)
Assets
Cash & cash equivalent11.34
Cash & Short-term Investments11.00
Other Receivables0.02
Grants Receivable, Current1.79
Other Current Assets0.00
Prepaid Expense And Other Assets Current0.89
Total Current Assets13.67
Equipment/Property/Plant Net1.18
Intangible Assets19.06
Long-term investments0.04
Other Assets, Noncurrent0.90
Deposits And Other Assets Noncurrent0.08
Total Assets34.86
Liabilities
Accounts Payable, Current AC0.98
Accrued Liabilities, Current6.42
Loans Payable, Current NO0.03
Other Liabilities, Current2.03
Business Combination, Contingent Consideration, Liability, Current BU2.65
Total Current Liabilities12.11
Long-term debt1.65
Total Long-term Debt1.65
Other liabilities, Noncurrent8.91
Operating Lease Liability Current1.43
Total Liabilities22.67
Stockholders' Equity
Common Stock Value0.05
Treasury Stock Value-0.29
Additional Paid In Capital Common Stock376.15
Retained Earnings / Accumulated Deficit-363.97
Accumulated Other Comprehensive Income0.25
Other Equity0.25
Common Stockholder's Equity12.19
Total Stockholder's Equity12.19
Liabilities & Stockholder's Equity34.86
4 historic quarters locked

Sign in to unlock the full Theriva Biologics inc balance sheet history.

About Theriva Biologics Inc Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-Q filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001104659-26-093786

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.